Open Access
CASE REPORT
Presentation of a functional pituitary adenoma as a significant decrease in prostate-specific antigen level in a patient followed for prostate cancer
Aaron B. Grotas, Harris M. Nagler
Department of Urology, Beth-Israel Medical Center, Albert Einstein College of Medicine, New York, New York, USA
Address correspondence to Dr. Aaron B. Grotas, Beth Israel
Department of Urology, 10 Union Square East, Suite 3A,
NY, New York 10003 USA
Canadian Journal of Urology 2006, 13(6), 3346-3347.
Abstract
The stimulatory role of testosterone in the production and
release of prostate-specific antigen (PSA) has been well
characterized. Testosterone production by the testes is
dependent on a functional hypothalamic-pituitary-gonadal
axis. High prolactin levels have been shown to disrupt this
axis, resulting in decreases in gonadotropins and testosterone
levels. We report a patient with prostate cancer and elevated
PSA levels followed with “watchful waiting” for several
years who experienced a precipitous decrease in PSA level
over a 3 month period. The patient was found to have an
asymptomatic prolactin-secreting pituitary macroadenoma.
Keywords
prostate specific antigen, prolactinoma, prostate cancer
Cite This Article
APA Style
Grotas, A.B., Nagler, H.M. (2006). Presentation of a functional pituitary adenoma as a significant decrease in prostate-specific antigen level in a patient followed for prostate cancer. Canadian Journal of Urology, 13(6), 3346–3347.
Vancouver Style
Grotas AB, Nagler HM. Presentation of a functional pituitary adenoma as a significant decrease in prostate-specific antigen level in a patient followed for prostate cancer. Can J Urology. 2006;13(6):3346–3347.
IEEE Style
A.B. Grotas and H.M. Nagler, “Presentation of a functional pituitary adenoma as a significant decrease in prostate-specific antigen level in a patient followed for prostate cancer,” Can. J. Urology, vol. 13, no. 6, pp. 3346–3347, 2006.
Copyright © 2006 The Canadian Journal of Urology.